• OPEN AN ACCOUNT
A+| A| A-|
Indian Indices
Sensex
77,186.87 1.44
( 0.00%)
Global Indices
Nasdaq
52,663.96 134.69
(0.26%)
Dow Jones
7,591.19 26.60
(0.35%)
Hang Seng
66,873.37 -1,878.14
(-2.73%)
Nikkei 225
10,555.24 39.32
(0.37%)
Forex
USD-INR
96.14 0.39
(0.40%)
EUR-INR
109.70 0.52
(0.48%)
GBP-INR
128.61 0.54
(0.42%)
JPY-INR
0.59 0.00
(0.41%)

EQUITY - MARKET SCREENER

Cipla Ltd
Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
ISIN Demat
Book Value()
500087
INE059A01026
423.3622252
NSE Symbol
P/E(TTM)
Mar.Cap( Cr.)
CIPLA
33.75
116164.12
EPS(TTM)
Face Value()
Div & Yield %
42.61
2
0.9
 

gb global ltd
Almondz Global Securities consolidated net profit declines 15.77% in the March 2026 quarter
May 22,2026
Net profit of Almondz Global Securities declined 15.77% to Rs 5.18 crore in the quarter ended March 2026 as against Rs 6.15 crore during the previous quarter ended March 2025. Sales rose 5.76% to Rs 55.79 crore in the quarter ended March 2026 as against Rs 52.75 crore during the previous quarter ended March 2025.

For the full year,net profit rose 65.72% to Rs 28.72 crore in the year ended March 2026 as against Rs 17.33 crore during the previous year ended March 2025. Sales rose 15.97% to Rs 173.54 crore in the year ended March 2026 as against Rs 149.64 crore during the previous year ended March 2025.

ParticularsQuarter EndedYear Ended
Mar. 2026Mar. 2025% Var.Mar. 2026Mar. 2025% Var.
Sales55.7952.75 6 173.54149.64 16
OPM %5.229.65 -14.5811.11 -
PBDT7.268.60 -16 38.7424.55 58
PBT5.887.54 -22 33.0520.28 63
NP5.186.15 -16 28.7217.33 66